Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Peters

Showing results (241-250 of 328) with videos related to

Pageof 33
Sort By:
Alcoholism, Clinical and Experimental Research|August 14, 2018
How Will Alcohol Research be Impacted by Future Reduction in Nicotine Content in Cigarettes?Erica N Peters, Evan S Herrmann, Amy M Cohn, et al.
The Journal of Biological Chemistry|June 1, 2001
Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathwayD Siegmund, D Mauri, N Peters, et al.
Drug and Alcohol Dependence|December 12, 2018
Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorderDustin C Lee, Nicolas J Schlienz, Erica N Peters, et al.
Cannabis and Cannabinoid Research|June 2, 2023
Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy AdultsLaura MacNair, Justyna Kulpa, Melanie L Hill, et al.
Journal of the National Cancer Institute|June 6, 2002
Loss of heterozygosity in benign breast epithelium in relation to breast cancer riskDavid M Euhus, Leslie Cler, Narayan Shivapurkar, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancerS E Jones, R G Mennel, G N Peters, et al.
British Journal of Haematology|September 1, 1991
Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukemiaA Raza, H Preisler, B Lampkin, et al.
European Journal of Neurology|August 19, 2014
Intravenous thrombolysis in stroke patients receiving rivaroxabanD J Seiffge, C Traenka, H Gensicke, et al.
Journal of Analytical Toxicology|March 12, 2021
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy ParticipantsErica N Peters, Irina Mosesova, Laura MacNair, et al.
Radiology|July 29, 2015
Accelerating MR Imaging Liver Steatosis Measurement Using Combined Compressed Sensing and Parallel Imaging: A Quantitative EvaluationLouis W Mann, David M Higgins, Carl N Peters, et al.
Pageof 33

Showing results (241-250 of 328) with videos related to

Sort By:
Pageof 33
Alcoholism, Clinical and Experimental Research|August 14, 2018
How Will Alcohol Research be Impacted by Future Reduction in Nicotine Content in Cigarettes?Erica N Peters, Evan S Herrmann, Amy M Cohn, et al.
The Journal of Biological Chemistry|June 1, 2001
Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathwayD Siegmund, D Mauri, N Peters, et al.
Drug and Alcohol Dependence|December 12, 2018
Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorderDustin C Lee, Nicolas J Schlienz, Erica N Peters, et al.
Cannabis and Cannabinoid Research|June 2, 2023
Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy AdultsLaura MacNair, Justyna Kulpa, Melanie L Hill, et al.
Journal of the National Cancer Institute|June 6, 2002
Loss of heterozygosity in benign breast epithelium in relation to breast cancer riskDavid M Euhus, Leslie Cler, Narayan Shivapurkar, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancerS E Jones, R G Mennel, G N Peters, et al.
British Journal of Haematology|September 1, 1991
Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukemiaA Raza, H Preisler, B Lampkin, et al.
European Journal of Neurology|August 19, 2014
Intravenous thrombolysis in stroke patients receiving rivaroxabanD J Seiffge, C Traenka, H Gensicke, et al.
Journal of Analytical Toxicology|March 12, 2021
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy ParticipantsErica N Peters, Irina Mosesova, Laura MacNair, et al.
Radiology|July 29, 2015
Accelerating MR Imaging Liver Steatosis Measurement Using Combined Compressed Sensing and Parallel Imaging: A Quantitative EvaluationLouis W Mann, David M Higgins, Carl N Peters, et al.
Pageof 33